Can-Fite BioPharma Ltd (CANF)
:CANF
US Market

Can-Fite BioPharma (CANF) Technical Analysis

Compare
563 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Can-Fite BioPharma Ltd’s (CANF) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Can-Fite BioPharma Ltd is a Buy.
Can-Fite BioPharma Ltd’s (CANF) 20-Day exponential moving average is 1.55, while Can-Fite BioPharma Ltd’s (CANF) share price is $1.47, making it a Sell.
Can-Fite BioPharma Ltd’s (CANF) 50-Day exponential moving average is 1.60, while Can-Fite BioPharma Ltd’s (CANF) share price is $1.47, making it a Sell.

Can-Fite BioPharma (CANF) Pivot Points

Apr 06, 2025, 11:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.42
1.43
1.46
1.47
1.50
1.51
1.54
Fibonacci
1.43
1.45
1.46
1.47
1.49
1.50
1.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Can-Fite BioPharma (CANF) Moving Averages

Apr 06, 2025, 11:55 PM
Period
Simple
Exponential
MA5
1.48Sell
1.49Sell
MA10
1.51Sell
1.51Sell
MA20
1.57Sell
1.55Sell
MA50
1.58Sell
1.60Sell
MA100
1.66Sell
1.72Sell
MA200
2.12Sell
2.02Sell
Can-Fite BioPharma Ltd’s (CANF) 10-Day exponential moving average is 1.51, while Can-Fite BioPharma Ltd’s (CANF) share price is $1.47, making it a Sell.
Can-Fite BioPharma Ltd’s (CANF) 100-Day exponential moving average is 1.72, while Can-Fite BioPharma Ltd’s (CANF) share price is $1.47, making it a Sell.
Can-Fite BioPharma Ltd’s (CANF) stock price is $1.47 and Can-Fite BioPharma Ltd’s (CANF) 50-day simple moving average is 1.58, creating a Sell signal.
Can-Fite BioPharma Ltd’s (CANF) stock price is $1.47 and Can-Fite BioPharma Ltd’s (CANF) 100-day simple moving average is 1.66, creating a Sell signal.
Can-Fite BioPharma Ltd’s (CANF) stock price is $1.47 and Can-Fite BioPharma Ltd’s (CANF) 200-day simple moving average is 2.12, creating a Sell signal.

Can-Fite BioPharma (CANF) Technical Indicators

Apr 06, 2025, 11:55 PM
Name
Value
Implied Action
RSI (14)
40.01
Neutral
STOCH (9,6)
4.81
Buy
STOCHRSI (14)
3.70
Buy
MACD (12,26)
-0.04
Buy
ADX (14)
33.12
Neutral
Williams %R
-97.89
Buy
CCI (14)
-140.91
Buy
ATR (14)
0.15
-
Ultimate Oscillator
35.62
Neutral
ROC
-10.91
Sell
Can-Fite BioPharma Ltd’s (CANF) Relative Strength Index (RSI) is 40.01, creating a Neutral signal.
Can-Fite BioPharma Ltd’s (CANF) Trend Strength Indicator (ADX) is 33.12, creating a Neutral signal.
Can-Fite BioPharma Ltd’s (CANF) Commodity Channel Index (CCI) is -140.91, creating a Buy signal.
Can-Fite BioPharma Ltd’s (CANF) Price Rate of Change (ROC) is -10.91, creating a Sell signal.

FAQ

Is CANF a Buy, Hold, or Sell?
Based on CANF’s technical indicators, CANF is a Strong Sell.
    What is CANF’s RSI (14)?
    CANF’s RSI (14) is 40.01, which suggests CANF is a Neutral.
      What is CANF’s MACD?
      CANF’s MACD is -0.04, which suggests CANF is a Buy.
        What is CANF’s 5-day moving average?
        CANF’s 5-day moving average is 1.48, which suggests CANF is a Sell.
          What is CANF’s 20-day moving average?
          CANF 20-day moving average is 1.57, which suggests CANF is a Sell.
            What is CANF’s 50-day moving average?
            CANF’s 50-day moving average is 1.58, which suggests CANF is a Sell.
              What is CANF’s 200-day moving average?
              CANF’s 200-day moving average is 2.12, which suggests CANF is a Sell.
                What is CANF’s Williams % R (14)?
                CANF’s Williams % R (14) is -97.89, which suggests CANF is a Buy.
                  What is CANF’s CCI (14)?
                  CANF’s CCI (14) is -140.91, which suggests CANF is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis